Discover five promising Prader-Willi syndrome therapies climbing the clinical ladder and nearing FDA approval in the coming ...
Aardvark Therapeutics Inc. (NASDAQ:AARD) is one of the best young stocks with huge upside potential. On October 8, Aardvark ...
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the best healthcare stocks with the highest upside. Goldman Sachs initiated ...
Harvey Price, who is autistic and has Prader-Willi syndrome, accidentally took two of mum Katie Price's CBD gummies and they ...
Aardvark erwartet erste Ergebnisse (Topline-Daten) aus der Phase-3-Studie HERO im dritten Quartal 2026. Das Unternehmen entwickelt zudem ARD-201, eine Kombinationstherapie aus ARD-101 und einem ...
(MENAFN- GetNews) The Key Prader-Willi Syndrome Companies in the market include - Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, ...
See more on the latest on Soleno Therapeutics (SLNO) stock after VYKAT XR approval. Learn why post-approval commercialization ...
The Fullerton all-girls Catholic school honored alumna Katie Webb Brundige, co-founder of RAD Camp (Rising Against ...
Investing.com -- Die Aktie von Soleno Therapeutics (NASDAQ:SLNO) legte um 14 % zu, nachdem der Konkurrent Acadia Pharmaceuticals (NASDAQ:ACAD) bekannt gab, dass seine Phase-3-Studie zur Behandlung des ...
KATIE Price has revealed that her son Harvey has lost 1.5st after starting fat jabs. She also revealed how he smashed THREE ...
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) released topline results on Wednesday from its Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients ...
Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback